MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES: $111M Department of Health and Human Services Grant
Summary
The Michigan Department of Health and Human Services received a $111M grant from SAMHSA for opioid response, focusing on prevention, treatment, and recovery. As a state-level award, no publicly traded companies directly benefit, but the contract signals continued federal investment in opioid abatement, supporting healthcare service providers and pharmaceutical manufacturers indirectly.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No publicly traded entity is directly funded by this $111M state grant.
- 2.The opioid treatment sector continues to receive substantial federal support, benefiting generic drug makers and treatment service providers.
- 3.Investors should monitor SAMHSA's SOR grant announcements for sector-wide demand signals but avoid over-attribution to specific companies.
Market Implications
The contract is a routine renewal of state-level opioid funding and does not create a material event for any single public company. The broader trend of sustained federal opioid spending (over $1B annually) provides a steady tailwind for pharmaceutical firms specializing in addiction treatments and naloxone distribution. However, without a direct tie to a specific ticker, the market impact is negligible for equity traders.
Full Analysis
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded the Michigan Department of Health and Human Services a $111M project grant under the State Opioid Response (SOR) initiative. The award runs from September 2024 to September 2027 and targets adults aged 25-44 with opioid use disorder, along with specific populations such as African Americans, adolescents, and American Indians/Alaska Natives. The program aims to expand access to naloxone, medication-assisted treatment (MOUD), harm reduction services, and recovery support. Since the recipient is a state government entity rather than a publicly traded company, no direct stock market impact is attributable. However, this contract is part of a broader federal push (over $1.5B annually in SOR grants) that benefits the entire opioid treatment ecosystem, including pharmaceutical firms producing buprenorphine, naloxone, and naltrexone, as well as behavioral health service providers. The related bills in the HillSignal database (e.g., S5006, S5116) are tangentially healthcare-related but lack specific provisions for opioid funding. Historically, similar SOR grants have sustained demand for addiction treatment services and medications, though the impact on individual public companies remains diffuse. Supply chain beneficiaries include manufacturers of naloxone (e.g., Amphastar, Emergent BioSolutions) and buprenorphine (Indivior, Dr. Reddy's), but no specific contract-level revenue attribution is possible. The contract's multi-year nature provides stable funding for Michigan's opioid response infrastructure.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
HEALTH CARE AUTHORITY: $82.7M Department of Health and Human Services Grant
PENNSYLVANIA DEPARTMENT OF DRUG AND ALCOHOL PROGRAMS: $253M Department of Health and Human Services Grant
FLORIDA DEPARTMENT OF CHILDREN AND FAMILIES: $318M Department of Health and Human Services Grant
MENTAL HEALTH & SUBSTANCE ABUSE SERVICES, TENNESSEE DEPARTMENT OF: $95.1M Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Women's Health to Improve Outcomes in All Phases of Life
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Contract Details
Recipient
MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES
Award Amount
$110,940,860
Awarding Agency
Department of Health and Human Services
Sub-Agency
Substance Abuse and Mental Health Services Administration
Contract Type
PROJECT GRANT (B)
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →